Outcome of long gap esophageal atresia at 6 years: A prospective case control cohort study.


Journal

Journal of pediatric surgery
ISSN: 1531-5037
Titre abrégé: J Pediatr Surg
Pays: United States
ID NLM: 0052631

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 18 05 2022
revised: 07 07 2022
accepted: 26 07 2022
pubmed: 16 8 2022
medline: 21 3 2023
entrez: 15 8 2022
Statut: ppublish

Résumé

EA is the most frequent congenital esophageal malformation. Long gap EA remains a therapeutic challenge for pediatric surgeons. A case case-control prospective study from a multi-institutional national French data base was performed to assess the outcome, at age of 1 and 6 years, of long gap esophageal atresia (EA) compared with non-long gap EA/tracheo-esophageal fistula (TEF). The secondary aim was to assess whether initial treatment (delayed primary anastomosis of native esophagus vs. esophageal replacement) influenced mortality and morbidity at ages 1 and 6 years. A multicentric population-based prospective study was performed and included all patients who underwent EA surgery in France from January 1, 2008 to December 31, 2010. A comparative study was performed with non-long gap EA/TEF patients. Morbidity at birth, 1 year, and 6 years was assessed. Thirty-one patients with long gap EA were compared with 62 non-long gap EA/TEF patients. At age 1 year, the long gap EA group had longer parenteral nutrition support and longer hospital stay and were significantly more likely to have complications both early post-operatively and before age 1 year compared with the non-long gap EA/TEF group. At 6 years, digestive complications were more frequent in long gap compared to non-long gap EA/TEF patients. Tracheomalacia was the only respiratory complication that differed between the groups. Spine deformation was less frequent in the long gap group. There were no differences between conservative and replacement groups at ages 1 and 6 years except feeding difficulties that were more common in the native esophagus group. Long gap strongly influenced digestive morbidity at age 6 years.

Sections du résumé

BACKGROUND DATA BACKGROUND
EA is the most frequent congenital esophageal malformation. Long gap EA remains a therapeutic challenge for pediatric surgeons. A case case-control prospective study from a multi-institutional national French data base was performed to assess the outcome, at age of 1 and 6 years, of long gap esophageal atresia (EA) compared with non-long gap EA/tracheo-esophageal fistula (TEF). The secondary aim was to assess whether initial treatment (delayed primary anastomosis of native esophagus vs. esophageal replacement) influenced mortality and morbidity at ages 1 and 6 years.
METHODS METHODS
A multicentric population-based prospective study was performed and included all patients who underwent EA surgery in France from January 1, 2008 to December 31, 2010. A comparative study was performed with non-long gap EA/TEF patients. Morbidity at birth, 1 year, and 6 years was assessed.
RESULTS RESULTS
Thirty-one patients with long gap EA were compared with 62 non-long gap EA/TEF patients. At age 1 year, the long gap EA group had longer parenteral nutrition support and longer hospital stay and were significantly more likely to have complications both early post-operatively and before age 1 year compared with the non-long gap EA/TEF group. At 6 years, digestive complications were more frequent in long gap compared to non-long gap EA/TEF patients. Tracheomalacia was the only respiratory complication that differed between the groups. Spine deformation was less frequent in the long gap group. There were no differences between conservative and replacement groups at ages 1 and 6 years except feeding difficulties that were more common in the native esophagus group.
CONCLUSIONS CONCLUSIONS
Long gap strongly influenced digestive morbidity at age 6 years.

Identifiants

pubmed: 35970676
pii: S0022-3468(22)00501-2
doi: 10.1016/j.jpedsurg.2022.07.023
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

747-755

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest All the authors declare that they have no conflict of interest.

Auteurs

Agate Bourg (A)

Pediatric Surgery Unit, University Hospital Center of Poitiers, 86000 Poitiers, France. Electronic address: agate.bourg@gmail.com.

Frédéric Gottrand (F)

Univ. Lille, CHU Lille, Reference center for rare esophageal diseases, Inserm U1286, F59000, Lille, France.

Benoit Parmentier (B)

Pediatric Surgery Unit, University Hospital Center of Poitiers, 86000 Poitiers, France.

Julie Thomas (J)

Pediatric Surgery Unit, University Hospital Center of Poitiers, 86000 Poitiers, France.

Anne Lehn (A)

Pediatric Surgery Unit, University Hospital of Strasbourg, 67200 Strasbourg, France.

Christian Piolat (C)

Pediatric Surgery Unit, University Hospital of Grenoble, 38700 Grenoble, France.

Arnaud Bonnard (A)

Pediatric Surgery Unit, Robert Debré Hospital APHP, 75019 Paris, France.

Rony Sfeir (R)

Pediatric Surgery Unit, University Hospital of Lille Jeanne de Flandre, 59000 Lille, France.

Julie Lienard (J)

Pediatric Surgery Unit, University Hospital of Nancy, 54035 Nancy, France.

Véronique Rousseau (V)

Pediatric Surgery Unit, Necker Hospital APHP, 75015 Paris, France.

Myriam Pouzac (M)

Pediatric Surgery Unit, Hospital of Orléans, 45100 Orléans, France.

Agnès Liard (A)

Pediatric Surgery Unit, University Hospital of Rouen, 76000 Rouen, France.

Philippe Buisson (P)

Pediatric Surgery Unit, University Hospital of Amiens-Picardie, 80054 Amiens, France.

Aurore Haffreingue (A)

Pediatric Surgery Unit, University Hospital of Caen Normandie, 14000 Caen, France.

Louis David (L)

Pediatric Surgery Unit, University Hospital of Dijon F.Mitterand, 21000 Dijon, France.

Sophie Branchereau (S)

Pediatric Surgery Unit, Bicetre Hospital APHP, 94270 Le Kremlin-Bicêtre, France.

Véronique Carcauzon (V)

Pediatric Surgery Unit, Hospital of Le Mans, 72000 Le Mans, France.

Nicolas Kalfa (N)

Pediatric Surgery Unit, University Hospital of Montpellier, 34295 Montpellier, France.

Marc-David Leclair (MD)

Pediatric Surgery Unit, University Hospital of Nantes Hotel Dieu, 44093 Nantes, France.

Hubert Lardy (H)

Pediatric Surgery Unit, University Hospital of Tours, 37000 Tours, France.

Sabine Irtan (S)

Pediatric Surgery Unit, Armand Trousseau Hospital APHP, 75012 Paris, France.

François Varlet (F)

Pediatric Surgery Unit, University Hospital of Saint-Etienne, 42055 Saint-Etienne Cedex 2.

Thomas Gelas (T)

Pediatric Surgery Unit, University Hospital of Lyon HCL Women Mother Children Hospital, 69500 Bron, France.

Diana Potop (D)

Pediatric Surgery Unit, University Hospital Center of Poitiers, 86000 Poitiers, France.

Marie Auger-Hunault (M)

Pediatric Surgery Unit, University Hospital Center of Poitiers, 86000 Poitiers, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH